Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Through manipulating the patent system, pharmaceutical companies are able to extend patent protection and potentially the market monopoly on their most profitable drugs
Same direction, entirely different magnitude
doi: 10.70389/pjs.100082 Summary Keywords chronic kidney transplant rejection, heterogeneity, kidney allograft rejection, metabolic profiles, single-cell RNA sequencing Citation Zhang Z, Zheng Y, Zheng L, He A, Chen J, Luo J, Wang M and Cai M (2026) Single-cell transcriptomic landscape of metabolic reprogramming in kidney allograft rejection
doi: 10.1016/S0022-5347(05)67987-6, 44 HuS.HaoY.ZhangX.YangY.LiuM.WangN.et al
10.3390/biomedicines9060620 191 RosselloX.RamallalR.RomagueraD.Alonso-Gmez
Atkuri, K.R., Mantovani, J.J., Herzenberg, L.A
US$ 27.86
US$ 27.68
US$ 22.60
US$ 22.46
US$ 21.85
